Wyniki wyszukiwania - AGRO

1

Activation induced cell death [AICD] in Jurkat line cells

100%

Filip A., Koczkodaj D., Kwiatkowska-Drabik B., Rozynkowa D.

Folia Histochemica et Cytobiologica. Supplement

|

1997

|

tom 35

|

nr 2

2

Peripheral blood B and T Cell profiles in children with active juvenile idiopathic arthritis

88%

Zahran A. M., Abdallah A. M., Saad K., Osman N. S., Youssef M. A. M., Abdel-Raheem Y. F., Elsayh K. I., Elgheet A. M. A., Darwish S. F., Alblihed M. A., Elhoufey A.

Archivum Immunologiae et Therapiae Experimentalis

|

2019

|

tom 67

|

nr 6

3

Two new cases of KIR3DP1, KIR2DL4-negative genotypes, one of which is also lacking KIR3DL2

88%

Niepieklo-Miniewska W., Zuk N., Dubis J., Kurpisz M., Senitzer D., Havrylyuk A., Grendziak R., Witkiewicz W., Chopyak V., Kusnierczyk P.

Archivum Immunologiae et Therapiae Experimentalis

|

2014

|

tom 62

|

nr 5

4

Changes in T lymphocyte potassium conductance in patients with renal failure

88%

Teisseyre A., Zmonarski S. C., Mozrzymas J. W., Klinger M.

Biophysics of Membrane Transport

|

1994

|

tom 12

|

nr 2

5

HLA-DR antigens in children with mumps meningitis

88%

Matej H., Kacprzak-Bergman I., Pacynska J., Nowakowska B., Kalamarz M.

Archivum Immunologiae et Therapiae Experimentalis

|

1992

|

tom 40

|

nr 2

6

The patch-clamp technique and its application in investigations of the properties of human T lymphocyte potassium channels

88%

Teisseyre A.

Cellular and Molecular Biology Letters

|

2001

|

tom 06

|

nr 1

7

Artykuł dostępny w postaci pełnego tekstu - kliknij by otworzyć plik

Cell-mediated response in nodular and ocular forms of human toxoplasmosis

88%

Dziubek Z., Zarnowska H., Gorski A., Basiak W., Kajfasz P., Bielawska M.

Wiadomości Parazytologiczne

|

1998

|

tom 44

|

nr 3

8

Extracellular potassium affects the inhibition of lymphocyte Kv1.3 channels by zinc

88%

Mozrzymas J. W., Teisseyre A.

Cellular and Molecular Biology Letters

|

2002

|

tom 07

|

nr Suppl.

9

T lymphocyte subpopulations in patients with chronic active hepatitis B virus infection characterized by monoclonal antibodies

75%

Dworniak D., Tchorzewski H., Pokoca L., Tkacz B., Drobnik S., Baj Z.

Archivum Immunologiae et Therapiae Experimentalis

|

1989

|

tom 37

|

nr 3-4

10

Altered expression of T lymphocyte surface markers in children with chronic autoimmune thyroiditis

75%

Kucharska A. M., Gorska E., Wasik M., Demkow U.

Journal of Physiology and Pharmacology. Supplement

|

2008

|

tom 59

|

nr 6

375-382

11

Comparative analysis of CD4 and CD8 lymphocytes - evidences for different distribution in primary and secondary liver tumors

75%

Giusca S. E., Wierzbicki P. M., Amalinei C., Caruntu I.-D., Avadanei E. R.

Folia Histochemica et Cytobiologica

|

2015

|

tom 53

|

nr 3

12

Functional exhaustion of T lymphocytes in chronic toxoplasmosis

75%

Dlugonska H., Grzybowski M. M.

Annals of Parasitology

|

2013

|

tom 59

|

nr 3

One of the most characteristic features of many intracellular parasite infections is their chronicity indicating that the host immune system is not capable of eradicating the pathogen. Toxoplasma gondii is the most successful parasite worldwide, infecting an extraordinarily broad range of hosts (endothermic animals and humans) and almost all cell types. Recent studies have revealed that in late chronic toxoplasmosis CD8⁺ T lymphocytes become progressively exhausted and this dysfunction is suggested to be responsible for the reactivation of latent infection, which may result in a life-threatening disease in immunocompromised individuals (e.g. neurotoxoplasmosis in AIDS patients). The article presents selected aspects of a new paradigm – T cell exhaustion phenomenon – a progressive dysfunction over time, which makes the host unable to control intracellular pathogen infections or tumours.

13

Apportioning blame: autoreactive CD4+ and CD8+ T cells in type 1 diabetes

75%

Varela‑Calvino R., Calvino-Sampedro C., Gomez-Tourino I., Cordero O. J.

Archivum Immunologiae et Therapiae Experimentalis

|

2017

|

tom 65

|

nr 4

14

Modulation of murine macrophages and T lymphocytes by lysozyme dimer

75%

Obminska-Mrukowicz B., Szczypka M., Gaweda B.

Polish Journal of Veterinary Sciences

|

2002

|

tom 05

|

nr 4

The effects of lysozyme dimer (2 and 20 μg/kg) administered i.p. once and four times to mice on the phagocytic and killing ability of peritoneal macrophages, interleukin-1 (IL-1) production by murine macrophages stimulated in vitro with lipopolisaccharide of E. coli and expression of thymocyte, splenocyte and mesenteric lymphonode cell CD3+, CD4+ and CD8+ markers were studied. It was found that lysozyme dimer administered once or four times at doses of 2 (μg/kg and 20 μg/kg augments the phagocytic and killing activity of peritoneal macrophages. The strongest stimulating effect was noted after four injections of lysozyme dimer at a dose of 20 μg/kg. Moreover, lysozyme dimer is able to modulate the production of IL-1 by murine macrophages stimulated in vitro with LPS. Exposure to four doses of lysozyme dimer (20 μg/kg) enhances the synthesis and release of IL-1, but this drug administered once (2 μg/kg and 20 μg/kg) or four times (2 μg/kg) decreases IL-1 production by peritoneal macrophages. It was also found that administration of lysozyme dimer at a dose of 20 μg/kg, irrespective of the number of doses applied, increases the percentage of CD4+ thymocytes and splenocytes. Moreover, exposure to four doses of lysozyme dimer (2 and 20 μg/kg) increases the percentage of CD4+ and CD8+ mesenteric lymphonode cells.

15

Antitumor effects of recombinant antivascular protein ABRaA-VEGF121 combined with IL-12 gene therapy

75%

Ciomber A., Smagur A., Mitrus I., Cichon T., Smolarczyk R., Sochanik A., Szala S., Jarosz M.

Archivum Immunologiae et Therapiae Experimentalis

|

2014

|

tom 62

|

nr 2

16

The T cell receptor in the mouse

75%

Uracz W.

Archivum Immunologiae et Therapiae Experimentalis

|

1989

|

tom 37

|

nr 1-2

17

The PPAR alpha pathway in V gamma 9V delta 2 T cell anergy

75%

Poupot M., Boissard F., Betous D., Bardouillet L., Fruchon S., L Faqihi-olive F., Pont F., Mekaouche M., Ingoure S., Sicard H., Dubreuilh G., Fournie J.-J.

Cellular and Molecular Biology Letters

|

2014

|

tom 19

|

nr 4

Phosphoantigens (PAgs) activate Vγ9Vδ2 T lymphocytes, inducing their potent and rapid response in vitro and in vivo. However, humans and nonhuman primates that receive repeated injections of PAgs progressively lose their Vγ9Vδ2 T cell response to them. To elucidate the molecular mechanisms of this in vivo desensitization, we analyzed the transcriptome of circulating Vγ9Vδ2 T cells from macaques injected with PAg. We showed that three PAg injections induced the activation of the PPARα pathway in Vγ9Vδ2 T cells. Thus, we analyzed the in vitro response of Vγ9Vδ2 T cells stimulated with a PPARα agonist. We demonstrated that in vitro PPARα pathway activation led to the inhibition of the BrHPP-induced activation and proliferation of human Vγ9Vδ2 T cells. Since the PPARα pathway is involved in the antigen-selective desensitization of human Vγ9Vδ2 T cells, the use of PPARα inhibitors could enhance cancer immunotherapy based on Vγ9Vδ2 T cells.

18

Cytokine signalling-transcription factor cross-talk in T cell activation and Th1-Th2 differentiation

75%

Liberman A. C., Refojo D., Arzt E.

Archivum Immunologiae et Therapiae Experimentalis

|

2003

|

tom 51

|

nr 6

19

Changes of membrane skeleton of dendritic cells during differentiation

75%

Kawiak J.

Cellular and Molecular Biology Letters

|

2001

|

tom 06

|

nr 2

20

Antigen-nonspecific activation of CD8plus T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer

75%

Ramanathan S., Gagnon J., Ilangumaran S.

Archivum Immunologiae et Therapiae Experimentalis

|

2008

|

tom 56

|

nr 5

Ograniczanie wyników